Mariette M. Pereira


This laboratory develops processes for drug synthesis, namely photosensitizers and potential antibiotics to inactivate viruses and bacteria by photodynamic therapy. It also synthesizes radiopharmaceuticals and new chemical entities for medical imaging with continuous flow techniques. Its interests in medicinal chemistry synthesis with industrial sustainable processes are focused on the preparation of catalysts for transforming CO and CO2 into molecules with potential biological activity and for the photodegradation of antibiotics in the environment. It was here that the first photosensitizer licensed for clinical trials in Portugal was discovered - redaporfin - developed by the spin-off Luzitin SA.